Tantigen Bio
Biotechnology Research
Philadelphia, Pa, United States
2 employees
- Employees
- 2
- Contacts
- 2
- Emails
- 2
- Phones
- 1
Tantigen Bio Overview
- Headquarters
- Philadelphia, Pa, United States
- Website
- www.tantigenbio.com
- Industry
- Biotechnology Research
- Employees
- 2
- Founded
- 2021
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
About Tantigen Bio
Tantigen is an early-stage immuno-oncology company developing the next generation of T cell therapies for patients with solid tumors. It is committed to solving the bottlenecks that limit the use of cell therapy in low mutational burden solid tumors enabling personalized, platform agnostic cell therapy for all. Tantigen is focused on the discovery of targets in pediatric cancers that are expressed across a range of adult indications, allowing development of treatments for neglected, rare indications as well as more common solid tumors.
Tantigen Bio Contact Details
- People in AeroLeads
- 2
- With contact data
- 2
- Email contacts
- 2
- 100.0% coverage
- Phone contacts
- 1
- 50.0% coverage
Tantigen Bio Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| John Maris | Professor at the Children's Hospital | Philadelphia, Pennsylvania, United States |
Email
Phone
|
| Mark Yarmarkovich, Phd | Principal Investigator & Assistant | New York, United States |
Email
|
Compare Similar Companies to Tantigen Bio
Candel Therapeutics
Biotechnology Research
Nabriva Therapeutics plc
Biotechnology Research
Altus Growth Partners
Business Consulting And Services
Spirovant Sciences, Inc.
Biotechnology Research
ThirdLaw Molecular
Biotechnology Research
MedSpa Network
Hospitals And Health Care
Eliksa Therapeutics
Biotechnology Research
Hula Therapeutics
Biotechnology
Histologic Innovations
Biotechnology Research
Life Sciences Workforce Collaborative
Non-Profit Organizations